Pharma faces more deceptive-marketing charges from states

04/23/2013 | Wall Street Journal, The

The pharmaceutical industry's potential liability widened after some U.S. states showed more aggressiveness in accusing drugmakers of deceptive marketing. Certain states have opted to act alone, which has led to heavy settlements and single-state awards. PhRMA Senior Vice President Matthew Bennett said "imposing state-law penalties on manufacturers for alleged violations of [federal drug law] raises serious legal and constitutional questions."

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC